Verve Therapeutics (VERV)
(Delayed Data from NSDQ)
$5.93 USD
+0.20 (3.49%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $5.94 +0.01 (0.17%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.70 | 0.00% |
Earnings Summary
For their last quarter, Verve Therapeutics (VERV) reported earnings of -$0.59 per share, beating the Zacks Consensus Estimate of $-0.68 per share. This reflects a positive earnings surprise of 13.24%. Look out for VERV's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.70 per share, reflecting a year-over-year increase of 2.78%.
Earnings History
Price & Consensus
Zacks News for VERV
Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates
VERV: What are Zacks experts saying now?
Zacks Private Portfolio Services